This project employs mass spectrometry-based proteomics to characterize the tissue-specific molecular mechanisms underlying the anti-obesity effects of leucic acid, a gut microbiota-derived metabolite. The goal is to identify protein networks and pathways modulated by leucic acid across key metabolic organs, with a current focus on the gonadal white adipose tissue (gWAT).